Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$884M |
| 2 |
Tesla
TSLA
|
+$641M |
| 3 |
Visa
V
|
+$520M |
| 4 |
Amazon
AMZN
|
+$457M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.14B |
| 2 |
Apple
AAPL
|
+$916M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$907M |
| 4 |
Microsoft
MSFT
|
+$832M |
| 5 |
Privia Health
PRVA
|
+$655M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.24% |
| 2 | Financials | 8.33% |
| 3 | Healthcare | 8.04% |
| 4 | Consumer Discretionary | 7.57% |
| 5 | Industrials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
Workhorse Group
WKHS
$33.2M
| $219K | ﹤0.01% |
84
+7
| +9% | +$20.2K |
|
|
GOEV
5027
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $218K | ﹤0.01% |
988
+74
| +8% | +$21.1K |
|
|
PROF
5028
Profound Medical
PROF
$268M
| $217K | ﹤0.01% |
+16,700
| New | +$207K |
|
5029
Ovid Therapeutics
OVID
$414M
| $217K | ﹤0.01% |
66,122
+54,948
| +492% | +$187K |
|
5030
Sight Sciences
SGHT
$286M
| $216K | ﹤0.01% |
26,100
-4,577
| -15% | -$41.2K |
|
5031
First Trust Nasdaq Pharmaceuticals ETF
FTXH
$56.4M
| $216K | ﹤0.01% |
+8,250
| New | +$218K |
|
5032
Corvus Pharmaceuticals
CRVS
$1.12B
| $216K | ﹤0.01% |
+94,311
| New | +$196K |
|
|
APCA
5033
DELISTED
AP Acquisition Corp
APCA
| $215K | ﹤0.01% |
20,000
| – | – |
|
|
ATXS
5034
DELISTED
Astria Therapeutics
ATXS
| $214K | ﹤0.01% |
25,633
-46,524
| -64% | -$537K |
|
|
NOTV
5035
DELISTED
Inotiv
NOTV
| $213K | ﹤0.01% |
44,740
-25,687
| -36% | -$142K |
|
5036
Humacyte
HUMA
$176M
| $213K | ﹤0.01% |
74,549
+11,666
| +19% | +$42.1K |
|
5037
Five Star Bancorp
FSBC
$1.14B
| $212K | ﹤0.01% |
9,493
-11,371
| -55% | -$231K |
|
|
SOND
5038
DELISTED
Sonder
SOND
| $212K | ﹤0.01% |
19,957
+15,857
| +387% | +$172K |
|
5039
Atlanticus Holdings
ATLC
$1.59B
| $211K | ﹤0.01% |
+5,023
| New | +$165K |
|
|
SWKH
5040
DELISTED
SWK Holdings
SWKH
| $211K | ﹤0.01% |
15,908
-6,182
| -28% | -$84.7K |
|
|
API
5041
Agora
API
$338M
| $210K | ﹤0.01% |
67,189
-76,180
| -53% | -$247K |
|
5042
Nkarta
NKTX
$150M
| $209K | ﹤0.01% |
95,332
+33,358
| +54% | +$147K |
|
|
WPRT
5043
Westport Fuel Systems
WPRT
$33.5M
| $208K | ﹤0.01% |
27,143
-486
| -2% | -$3.75K |
|
5044
HF Foods Group
HFFG
$80.2M
| $208K | ﹤0.01% |
44,384
+26,327
| +146% | +$103K |
|
5045
John Marshall Bancorp
JMSB
$327M
| $208K | ﹤0.01% |
+10,356
| New | +$206K |
|
|
VZLA
5046
Vizsla Silver
VZLA
$1.1B
| $207K | ﹤0.01% |
169,680
+93,930
| +124% | +$126K |
|
5047
Braskem
BAK
$928M
| $206K | ﹤0.01% |
+17,647
| New | +$167K |
|
5048
Foster
FSTR
$430M
| $206K | ﹤0.01% |
14,394
+184
| +1% | +$2.27K |
|
|
RAD
5049
DELISTED
Rite Aid Corporation
RAD
| $205K | ﹤0.01% |
135,752
-36,052
| -21% | -$72.2K |
|
|
FCT
5050
First Trust Senior Floating Rate Income Fund II
FCT
$251M
| $205K | ﹤0.01% |
20,676
+1,000
| +5% | +$9.68K |
|
Similar funds
Goldman Sachs's Q2 2023 Portfolio in Review
As of Q2 2023, Goldman Sachs held 6,313 positions worth $466B, up 7.1% from $435B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q2 2023 filing shows 443 new, 2,419 increased, 2,272 reduced and 593 closed positions. Its largest new stake was Pelagos Insurance Capital: 15,246,144 shares worth $208M. The largest sale was Invesco QQQ Trust, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q2 2023 buy was Pelagos Insurance Capital: 15,246,144 shares worth $208M.
- Goldman Sachs added most to Alphabet (Google) Class A in Q2 2023, an estimated $884M increase.
- Goldman Sachs's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.14B.
- Goldman Sachs fully exited DCP Midstream, LP in Q2 2023, selling an estimated $250M.
- Goldman Sachs's ten largest holdings make up 19% of its $466B portfolio in Q2 2023.
- Goldman Sachs opened 443 new positions and closed 593 in Q2 2023.
- Goldman Sachs's portfolio value rose 7.1% quarter-over-quarter to $466B.
Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.